EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

King’s stages of amyotrophic lateral sclerosis: an 18F-FDG-PET study of brain connectivity

Francesca Di Pede iD, Sara Cabras, Umberto Manera iD, Rosario Vasta, Grazia Zocco, Emilio Minerva, Enrico Matteoni, Filippo De Mattei, Giorgio Pellegrino, Francesca Palumbo, Daniela Pascariu, Stefano Callegaro und 9 weitere

Brain · 2026

DOI: 10.1093/brain/awag159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2026. Verfasst von Francesca Di Pede und 20 weiteren Autor:innen. Beteiligte Einrichtung: ALS Centre, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin 10126, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Progetti di Rilevante Interesse Nazionale (PRIN), Joint Programme-Neurodegenerative Disease Research, Italian Ministry of Education, University and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting upper and lower motor neurons. TAR DNA-binding protein 43 (TDP-43) proteinopathy is the neuropathological signature of the disease, and 18F-fluorodeoxyglucose PET (18F-FDG-PET) serves as a marker of neurodegeneration in vivo. The aim of the present cross-sectional study was to disentangle 18F-FDG-PET correlates of disease severity assessed through the King’s staging system, by exploring connectivity changes across motor stages. Patients with ALS classified as King’s stage 1, 2 or 3, who underwent brain 18F-FDG-PET at diagnosis from 2008 to 2022 at the ALS Centre of Turin, were included. A multiple regression analysis to evaluate the relationship between brain metabolism and King’s stage was performed. The clusters showing significant results were used as seed regions in an interregional correlation analysis (IRCA), performed for each stage. Of a total of 832 patients with ALS, 337 were classified as King’s stage 1, 274 as stage 2 and 221 as stage 3. The three groups significantly differed in age at PET, disease duration and total ALS Functional Rating Scale Revised (ALSFRS-R) score at the time of PET, C9orf72 status and the distribution of cognitive categories. We found a decreasing metabolic gradient from King’s stage 1 to King’s stage 3 in a cluster encompassing motor and cognitive areas. As King’s stage increases, we found a decrease of connectivity within the sensorimotor and cognitive areas. The IRCA also showed the connectivity of motor and cognitive regions with temporal and cerebellar regions. The connectivity with temporal regions found in King’s stage 1 decreases in King’s stage 2 and finally, disappears in King’s stage 3. The connectivity with the cerebellum occurs in King’s stage 2 and decreases in King’s stage 3. The changes of connectivity of motor and cognitive areas with temporal and cerebellar regions among different King’s stages might reflect the spread of TDP-43 proteinopathy or a compensatory mechanism, respectively. The present study suggests that 18F-FDG-PET imaging of the brain may be integrated with the King’s staging system to assess the extent of the pathogenic process in the context of clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisBrainHumansPositron-Emission TomographyFluorodeoxyglucose F18FemaleMaleCross-Sectional StudiesMiddle AgedAgedSeverity of Illness IndexDisease Progression

Stichwörter der Autor:innen

18F-FDG-PETKing’s staging systemamyotrophic lateral sclerosisconnectivity

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • ALS Centre, 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin 10126, Italy.
  • School of Advanced Studies, Centre for Neuroscience, University of Camerino, Camerino 62032, Italy.
  • Neurology Unit 1U, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin 10126, Italy.
  • Positron Emission Tomography Centre AFFIDEA-IRMET S.p.A., Turin 10135, Italy.
  • Department of AI, Data and Decision Sciences, LUISS Guido Carli University, Rome 00197, Italy.
  • Environment and Health Department, Istituto Superiore di Sanità, Rome 00161, Italy.

ORCID-Profile: Francesca Di Pede, Umberto Manera, Alessandro Giuliani, Andrea Calvo, Adriano Chiò

Förderung

  • Progetti di Rilevante Interesse Nazionale (PRIN)
  • Joint Programme-Neurodegenerative Disease Research
  • Italian Ministry of Education, University and Research
  • Thierry Latran Foundation
  • Italian Ministry of Health
  • European Commission's Health Seventh Framework Programme
  • European Union's Horizon 2020 research and innovation programme
  • A.S.D. Polisportiva U.I.C.I Torino Onlus

Zitieren

APA

Di Pede, F., Cabras, S., Manera, U., Vasta, R., Zocco, G., Minerva, E., Matteoni, E., De Mattei, F., Pellegrino, G., Palumbo, F., Pascariu, D., Callegaro, S., Maccabeo, A., Polverari, G., Martino, A., Giuliani, A., Moglia, C., Calvo, A., Chiò, A., …, & Canosa, A. (2026). King’s stages of amyotrophic lateral sclerosis: an 18F-FDG-PET study of brain connectivity. Brain. https://doi.org/10.1093/brain/awag159

Vancouver

Di Pede F, Cabras S, Manera U, Vasta R, Zocco G, Minerva E, et al. King’s stages of amyotrophic lateral sclerosis: an 18F-FDG-PET study of brain connectivity. Brain. 2026. doi:10.1093/brain/awag159

BibTeX
@article{DiPede2026,
  author = {Di Pede, Francesca and Cabras, Sara and Manera, Umberto and Vasta, Rosario and Zocco, Grazia and Minerva, Emilio and Matteoni, Enrico and De Mattei, Filippo and Pellegrino, Giorgio and Palumbo, Francesca and Pascariu, Daniela and Callegaro, Stefano and Maccabeo, Alessandra and Polverari, Giulia and Martino, Alessio and Giuliani, Alessandro and Moglia, Cristina and Calvo, Andrea and Chiò, Adriano and Pagani, Marco and Canosa, Antonio},
  title = {King’s stages of amyotrophic lateral sclerosis: an 18F-FDG-PET study of brain connectivity},
  journal = {Brain},
  year = {2026},
  doi = {10.1093/brain/awag159}
}
Kostenlos starten →